Uveitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years of age or older (male or female)
- You have given your free, written consent to participate before any study-related tests are done
- You are covered by a social security or health insurance system
- You have a condition affecting one or both eyes that falls into one of the following groups:
- Group 1: Eye inflammation (uveitis) that has been diagnosed as something other than eye lymphoma, and you do not have brain lymphoma
- Group 2: Primary eye lymphoma (cancer affecting the eye) with no brain involvement, and you have never been treated for it
- Group 3: Primary eye lymphoma with no brain involvement, previously treated, and currently considered to be in remission (confirm with trial site)
- Group 4: Primary eye lymphoma with no brain involvement, and currently considered to have relapsed (confirm with trial site)
- Group 5: Brain lymphoma, with or without eye involvement, but no eye inflammation (uveitis)
- Group 6: Cataracts (before or after surgery), glaucoma, retinal detachment, or a membrane growing over the retina — with no brain damage or eye inflammation
Who may not be able to join:
- You are currently taking part in another clinical trial
- You are pregnant, in labour, or currently breastfeeding
- You are currently deprived of your liberty by a legal or administrative decision
- You are currently receiving psychiatric care
- You are currently living in a health or social care institution for reasons unrelated to research
- You are an adult under a legal protection measure such as guardianship or curatorship
- Your diagnosis of eye or brain lymphoma is uncertain or unconfirmed
- You have another type of cancer elsewhere in the body that is either currently active or has been in remission for less than 2 years
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 4 26 10 93 22
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
percentage of NK Cells in blood with phenotype acquired by trogocytosis (WO/2016/005548) in patients with uveitis with a diagnosis other than ocular lymphoma and without cerebral lymphoma (Negative control); percentage of NK Cells in blood with phenotype acquired by trogocytosis (WO/2016/005548) in patients with primary ocular lymphoma without brain involvement and never treated
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.